Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Genetics of enzymatic dysfunctions in metabolic disorders and cancer.
Front Oncol. 2023 Aug 2;13:1230934. doi: 10.3389/fonc.2023.1230934. eCollection 2023.
Front Oncol. 2023.
PMID: 37601653
Free PMC article.
Review.
Ganoderma lucidum enhances carboplatin chemotherapy effect by inhibiting the DNA damage response pathway and stemness.
Suárez-Arroyo IJ, Acevedo-Díaz A, Ríos-Fuller TJ, Ortiz-Soto G, Vallejo-Calzada R, Reyes-Chea J, Maldonado-Martínez G, Schneider RJ, Martínez-Montemayor MM.
Suárez-Arroyo IJ, et al. Among authors: rios fuller tj.
Am J Cancer Res. 2022 Mar 15;12(3):1282-1294. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 35411244
Free PMC article.
Item in Clipboard
Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs).
Rios-Fuller TJ, Mahe M, Walters B, Abbadi D, Pérez-Baos S, Gadi A, Andrews JJ, Katsara O, Vincent CT, Schneider RJ.
Rios-Fuller TJ, et al.
Int J Mol Sci. 2020 Jul 26;21(15):5301. doi: 10.3390/ijms21155301.
Int J Mol Sci. 2020.
PMID: 32722591
Free PMC article.
Review.
Item in Clipboard
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway.
Rios-Fuller TJ, Ortiz-Soto G, Lacourt-Ventura M, Maldonado-Martinez G, Cubano LA, Schneider RJ, Martinez-Montemayor MM.
Rios-Fuller TJ, et al.
Oncotarget. 2018 Nov 13;9(89):35907-35921. doi: 10.18632/oncotarget.26294. eCollection 2018 Nov 13.
Oncotarget. 2018.
PMID: 30542507
Free PMC article.
Item in Clipboard
Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression.
Suárez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alviarez DJ, Maldonado-Martinez G, Cubano LA, Martínez-Montemayor MM.
Suárez-Arroyo IJ, et al. Among authors: rios fuller tj.
J Cancer. 2016 Feb 5;7(5):500-11. doi: 10.7150/jca.13599. eCollection 2016.
J Cancer. 2016.
PMID: 26958085
Free PMC article.
Item in Clipboard
Cite
Cite